학술논문
Amaurosis Fugax: A Rare Oxaliplatin-Induced Ocular Toxicity - A Report of Three Cases
Document Type
Clinical report
Source
Case Reports in Oncology. January 2022, Vol. 15 Issue 1, p133, 5 p.
Subject
Language
English
Abstract
Author(s): Mutahar Ali Tunio [a]; Karen Phillips [b]; Peter Baker [c] Introduction Oxaliplatin is a third-generation platinum analogue, which is commonly prescribed in combination with fluorouracil/folinic acid, or capecitabine during [...]
Oxaliplatin, a third-generation platinum-based agent, is a constitutive part of systemic treatment for colorectal cancer in adjuvant and metastatic settings. Ocular toxicity is an extremely rare adverse effect of Oxaliplatin. Ocular toxicities have been documented in the form of (a) common ([GreaterEqual]1/100, Keywords: Oxaliplatin, Toxicity, Ocular, Amaurosis fugax
Oxaliplatin, a third-generation platinum-based agent, is a constitutive part of systemic treatment for colorectal cancer in adjuvant and metastatic settings. Ocular toxicity is an extremely rare adverse effect of Oxaliplatin. Ocular toxicities have been documented in the form of (a) common ([GreaterEqual]1/100, Keywords: Oxaliplatin, Toxicity, Ocular, Amaurosis fugax